Vogenx to Present Mizagliflozin Phase 2 Data at ENDO 2025
15 Apr 2025 //
ACCESSWIRE
Vogenx Announces Positive Phase 2 Results For Mizagliflozin In Hypoglycemia
26 Jun 2024 //
ACCESSWIRE
Vogenx Completes Dosing of Last Patient in Ph 2 Study of Mizagliflozin
02 Apr 2024 //
ACCESSWIRE
Vogenx Completes Enrollment of Phase 2 Trial of Mizagliflozin
15 Feb 2024 //
ACCESSWIRE